menu
    • menu

    Company profile for Essa Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ESSA’s initial focus is in the treatment of prostate cancer. Prostate cancer is a male hormone (androgen) driven malignancy, and six decades of drug development have resulted in continuous improvements in anti-androgen therapy. Yet resistance commonly develops to drugs. ESSA had developed a new class of drugs, the “anitens”. These drugs interrupt androgen-driven biology in a novel manner and are active even in the set...
    ESSA’s initial focus is in the treatment of prostate cancer. Prostate cancer is a male hormone (androgen) driven malignancy, and six decades of drug development have resulted in continuous improvements in anti-androgen therapy. Yet resistance commonly develops to drugs. ESSA had developed a new class of drugs, the “anitens”. These drugs interrupt androgen-driven biology in a novel manner and are active even in the setting of resistance to current anti-androgen therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Essa PharmaCanada Flag
    Country
    Country
    Canada
    Address
    Address
    999 West Broadway, Suite 720 Vancouver, BC V5Z 1K5 Canada
    Telephone
    Telephone
    (778) 331-0962
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.essapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/essa-pharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/essapharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ESSA Announces Completion Of Arrangement With Xenotherapeutics
    ESSA Announces Completion Of Arrangement With Xenotherapeutics

    09 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/essa-announces-completion-of-arrangement-with-xenotherapeutics-302579249.html

    PR NEWSWIRE
    09 Oct 2025
    Share Share
    ESSA Securityholders Approve Acquisition By Xenotherapeutics
    ESSA Securityholders Approve Acquisition By Xenotherapeutics

    06 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/essa-securityholders-approve-acquisition-by-xenotherapeutics-302576261.html

    PR NEWSWIRE
    06 Oct 2025
    Share Share
    Essa Pharma Updates Application For Amended Interim Order
    Essa Pharma Updates Application For Amended Interim Order

    01 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/essa-pharma-inc-provides-update-on-its-application-to-the-supreme-court-of-british-columbia-for-amended-interim-order-302571472.html

    PR NEWSWIRE
    01 Oct 2025
    Share Share
    Essa Pharma Amends Agreement With Xenotherapeutics
    Essa Pharma Amends Agreement With Xenotherapeutics

    24 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/essa-pharma-inc-amends-agreement-with-xenotherapeutics-302565262.html

    PR NEWSWIRE
    24 Sep 2025
    Share Share
    Essa Pharma Inc. Reschedules Special Meeting to Sept 29, 2025
    Essa Pharma Inc. Reschedules Special Meeting to Sept 29, 2025

    10 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/essa-pharma-inc-to-adjourn-special-meeting-to-september-29-2025-302551833.html

    PR NEWSWIRE
    10 Sep 2025
    Share Share
    Essa Pharma Clarifies Nasdaq Due Bill Trade for Cash Distributor
    Essa Pharma Clarifies Nasdaq Due Bill Trade for Cash Distributor

    25 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/essa-pharma-inc-clarifies-nasdaq-due-bill-trading-for-previously-announced-cash-distribution-302538003.html

    PR NEWSWIRE
    25 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search